High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy

High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy

BackgroundBreast cancer is the most commonly diagnosed cancer worldwide. However, the well-known biomarkers are not enough to meet the needs of precision medicine. Novel targets are desirable and highly valuable for improved patient survival. In this regard, we identified complement component C7 as...

Full description

Bibliographic Details
Main Authors: Huikun Zhang, Yawen Zhao, Xiaoli Liu, Li Fu, Feng Gu, Yongjie Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
C7
breast cancer
prognosis
TE chemotherapy
bone metastasis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.724250/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.724250/full

Similar Items